Dr Pardeep Narula Email & Phone Number

Chandigarh Area, India

Working as Vice president heading R&D team comprising of API Generic research , Crams , Analytical division and IPR deptts. Heading a team of around 140 people .

ZANDU CHEMICALS LIMITED General Manager Corporate R&D & RA Since Dec 07 Presently working in Head Office of Zandu as General manager Corporate QA ,RA and R&D.  Responsible for Technology development and their validation in laboratory for Phenothiazine based API’s like Trifluoperazine, Fluphenazine ,Cinnarzine and others API like Nabilone and Isotretinoin. Responsible for Technology transfer to plant of All API’s and their implementation for scale up. Responsible for preparation of Technology transfer documents . Responsible for preparation and filing of DMF in regulated markets in US and Europe.  Being as Head corporate For QA and Regulatory responsible for documentation of SOP’s, Validation Master Plan, and internal audits in plant.

Technical Director Aug’03-Jan’04Director Since Jan’04Production , Quality control and Quality Assurance Notable Milestones Filed Drug Master File in US and Europe for Lovastatin in May’04 and got FDA approval in Apr’05 (Faced FDA as Management representative).  • A new process of Isolation and preparation of Lovastatin from Fermentation broth, Process patent granted in PCT WO 02/00615 A2.• A new process of Lactonization in statins.• A new process for Lovastatin having dimer content in the range of 0.2 to 0.3 %.• A new process for preparation of sodium salt of Pravastatin & other statins. Process patent granted in PCT WO 01/44144 A2.• A new method of preparation of Pravastatin sodium having TRS  0.5% in the finished good.• A new process of Isolation and preparation of Orlistat from • • A new process for making Mycophenolate moffetil and Mycophenolic acid sodium from Mycophenolinic acid.

As Group leader in ranbaxy laboratories ltd